Literature DB >> 11060351

Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype.

R Frikke-Schmidt1, B G Nordestgaard, B Agerholm-Larsen, P Schnohr, A Tybjaerg-Hansen.   

Abstract

Variation in apolipoprotein (apo)E genotypes predicts variation in plasma cholesterol and apoB; however, the context-dependent associations between high density lipoprotein (HDL) cholesterol, apoA-I, triglycerides, and lipoprotein[a] (Lp[a]) and this polymorphism remain unsettled. We genotyped 5,025 women and 4,035 men sampled to represent a white general population in the age range 20 to 80+ years (mean ages 58 and 57 years for women and men, respectively). The relative frequencies of the varepsilon22, varepsilon32, varepsilon42, varepsilon33, varepsilon43, and varepsilon44 genotypes were 0.005, 0.127, 0.027, 0.564, 0.251, and 0. 027, respectively. Variations in apoE genotype (in the order listed above) predicted stepwise increases in cholesterol and apoB in both genders (all ANOVAs: P < 0.001), and stepwise decreases in HDL cholesterol and apoA-I in women (both ANOVAs: P < 0.001), but not in men. In both genders varepsilon33 individuals had the lowest levels of nonfasting triglycerides, whereas the highest levels were found in individuals with varepsilon22 and varepsilon44 genotypes (both ANOVAs: P < 0.001). Finally, a stepwise increase in Lp[a] was seen in women (ANOVA: P < 0.001), but not in men. In women, the association between variation in nonfasting triglycerides and Lp[a], and variation in apoE genotypes was mainly seen in those with the highest alcohol consumption, similar to the consumption of most men. Variations in apoE genotype predicted 5% and 11% in women, and 2% and 6% in men, of the total variation in plasma cholesterol and apoB, respectively. Variation in levels of plasma lipoproteins is associated with variation in apoE genotypes in the population at large, with the most pronounced association in women, except for nonfasting triglycerides, for which the association is most pronounced in men.Whereas the associations between variation in plasma cholesterol and apoB and the variation in apoE genotypes seem invariant, the associations with variation in plasma HDL cholesterol, apoA-I, nonfasting triglycerides, and Lp[a] seem context dependent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11060351

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  22 in total

1.  Apolipoprotein E polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the Genetics of Lipid Lowering and Diet Network (GOLDN) Study.

Authors:  Marguerite R Irvin; Edmond K Kabagambe; Hemant K Tiwari; Laurence D Parnell; Robert J Straka; Michael Tsai; Jose M Ordovas; Donna K Arnett
Journal:  Circ Cardiovasc Genet       Date:  2010-08-21

Review 2.  Is hypercholesterolemia a risk factor for Alzheimer's disease?

Authors:  W Gibson Wood; Urule Igbavboa; Gunter P Eckert; Leslie N Johnson-Anuna; Walter E Müller
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

3.  Genome- and exome-wide association study of serum lipoprotein (a) in the Jackson Heart Study.

Authors:  Jin Li; Leslie A Lange; Jeremy Sabourin; Qing Duan; William Valdar; Monte S Willis; Yun Li; James G Wilson; Ethan M Lange
Journal:  J Hum Genet       Date:  2015-09-17       Impact factor: 3.172

4.  An application of the patient rule-induction method for evaluating the contribution of the Apolipoprotein E and Lipoprotein Lipase genes to predicting ischemic heart disease.

Authors:  Greg Dyson; Ruth Frikke-Schmidt; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Charles F Sing
Journal:  Genet Epidemiol       Date:  2007-09       Impact factor: 2.135

5.  Innovative Research Design Exploring the Effects of Physical Activity and Genetics on Cognitive Performance in Community-Based Older Adults.

Authors:  Jennifer L Etnier; Jeffrey D Labban; William B Karper; Laurie Wideman; Aaron T Piepmeier; Chia-Hao Shih; Michael Castellano; Lauren M Williams; Se-Yun Park; Vincent C Henrich; William N Dudley; Kelli L Rulison
Journal:  J Aging Phys Act       Date:  2015-01-16       Impact factor: 1.961

6.  Sex-specific interaction between APOE genotype and carbohydrate intake affects plasma HDL-C levels: the Strong Heart Family Study.

Authors:  M J Mosher; L A Lange; B V Howard; E T Lee; L G Best; R R Fabsitz; J W Maccluer; K E North
Journal:  Genes Nutr       Date:  2008-03-29       Impact factor: 5.523

7.  Heritabilities, apolipoprotein E, and effects of inbreeding on plasma lipids in a genetically isolated population: the Erasmus Rucphen Family Study.

Authors:  Aaron Isaacs; Fakhredin A Sayed-Tabatabaei; Yurii S Aulchenko; M Carola Zillikens; Eric J G Sijbrands; Anna F C Schut; Wim P F Rutten; Huibert A P Pols; Jacqueline C M Witteman; Ben A Oostra; Cornelia M van Duijn
Journal:  Eur J Epidemiol       Date:  2007-02-21       Impact factor: 8.082

Review 8.  Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.

Authors:  Eva Boes; Stefan Coassin; Barbara Kollerits; Iris M Heid; Florian Kronenberg
Journal:  Exp Gerontol       Date:  2008-11-17       Impact factor: 4.032

9.  Variation in 5' promoter region of the APOE gene contributes to predicting ischemic heart disease (IHD) in the population at large: the Copenhagen City Heart Study.

Authors:  J H Stengård; R Frikke-Schmidt; A Tybjaerg-Hansen; B G Nordestgaard; C F Sing
Journal:  Ann Hum Genet       Date:  2007-05-29       Impact factor: 1.670

10.  Gender- and age-specific contributions of additional DNA sequence variation in the 5' regulatory region of the APOE gene to prediction of measures of lipid metabolism.

Authors:  Ruth Frikke-Schmidt; Charles F Sing; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Journal:  Hum Genet       Date:  2004-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.